Previous close | 232.29 |
Open | 235.58 |
Bid | 227.83 x 900 |
Ask | 245.25 x 800 |
Day's range | 233.99 - 239.95 |
52-week range | 167.42 - 261.73 |
Volume | |
Avg. volume | 1,249,483 |
Market cap | 43.692B |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | 31.17 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RESEARCH TRIANGLE PARK, N.C., July 22, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2024.
RESEARCH TRIANGLE PARK, N.C., July 11, 2024--IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiveness.
RESEARCH TRIANGLE PARK, N.C., July 08, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.